文献速递免疫规划传染病防控与疫情报告

猪对野猪源重组戊型肝炎病毒衣壳蛋白免疫的适应性免疫应答

Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs.
PubMed 文献 · Vaccine · 2024-11-30

本研究将野猪源重组HEV-3衣壳蛋白(rORF2p,aa 112-608)以1 ml 200 μg/ml接种4头6周龄猪,14天后加强免疫,采血至初次免疫后28天。免疫猪检测到显著抗HEV IgG、单核/巨噬细胞、B细胞和T细胞应答,提示rORF2p可诱导猪免疫应答,有作为疫苗候选的潜力。

要点

  • 4头6周龄猪接种1 ml 200 μg/ml rORF2p,14天后加强,采血至28天。
  • 免疫猪检测到显著抗HEV IgG、单核/巨噬细胞、B细胞和T细胞应答。
  • 作者认为rORF2p可诱导猪免疫应答,提示其有作为疫苗候选的潜力。

核心结论

  • 作者认为rORF2p能诱导猪免疫应答,提示其有作为疫苗候选的潜力。

研究设计与样本

  • 研究用野猪源重组HEV-3衣壳蛋白(rORF2p,aa 112-608)免疫猪,4头6周龄猪接种1 ml 200 μg/ml rORF2p,14天后加强,采血至初次免疫后28天。

主要发现

  • 免疫猪检测到显著抗HEV IgG应答。
  • 免疫猪检测到显著单核/巨噬细胞、B细胞和T细胞应答。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis E virus genotype 3 (HEV-3) is a zoonotic pathogen capable of infecting human, porcine, and other animal hosts. Despite a broad host range and abundance of species that act as reservoirs for human infections, no commercially available animal vaccines against HEV-3 are currently available. In the present study, we tested the capacity of recombinant aa 112-608 wild boar-derived HEV-3 capsid protein (rORF2p) to induce an immune response in immunized pigs. Four 6 week old pigs were administered 1 ml of 200 μg/ml rORF2p, followed by booster administration after 14 days. Blood samples were collected until 28 days after initial immunization. Dominant cell phenotypes and anti-HEV IgG concentrations were determined. A significant anti-HEV IgG, monocyte/macrophage, B cell and T cell response has been detected in immunized pigs. In turn, our findings suggest the capacity of rORF2p to elicit an immune response in pigs, suggesting the potential for its use as a vaccine candidate.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Grigas J, Spancerniene U, Simanavicius M, et al. Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs. Vaccine. 2024. PMID: 39617676. doi:10.1016/j.vaccine.2024.126561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。